The contribution of low grade inflammation of CKD to the inhibition of HIF2 upregulation (Figs 1 and 2) is an attractive hypothesis, as previously described in a recent model of EPO resistance in CKD rats [28]. The gene discussed is EPO; the disease is chronic kidney disease.